Medicine
Chapter 7
Section 15.1
Neurology And Neuromuscular
Services
Issue Date: April 19, 1983
Copyright: CPT
only © 2006 American Medical Association (or such other date of
publication of CPT).
All Rights Reserved.
Revision: C-61, April 17, 2020
1.0 CPT
PROCEDURE CODEs
20552, 20553, 95812 - 95999
2.0 HCPCS Procedure Code
J9310
3.0 DESCRIPTION
The
diagnosis and treatment of muscle and nerve disorders.
4.0 POLICY
4.1 Neurology and neuromuscular services are covered.
4.2 The Epley Canalith Repositioning Procedure
(CRP) is covered for the treatment of Benign Paroxysmal Positional
Vertigo (BPPV) with an effective date of June 13, 2012.
4.3 Off-label use of rituximab may be considered
for cost-sharing for the treatment of Chronic Inflammatory Demyelinating
Polyneuropathy (CIDP). The effective date is July 16, 2010.
4.4 Off-label use of rituximab injections may be
considered for cost-sharing for the treatment of Stiff Person Syndrome.
The effective date is March 31, 2005.
4.5 Off-label use of rituximab injections may be
considered for cost-sharing for the treatment of Multiple Sclerosis
(MS). The effective date is February 14, 2008.
5.0 Exclusions
5.1 Topographic
brain mapping (HCPCS S8040) is unproven.
5.2 Microcurrent Electrical Therapy
(MET), Cranial Electrotherapy Stimulation (CES), or any therapy that
uses the non-invasive application of low levels of microcurrent
stimulation to the head by means of external electrodes for the
treatment of anxiety, depression, insomnia, Post-Traumatic Stress Disorder
(PTSD), pain, or migraines and electrical stimulation devices used
to apply this therapy, are unproven.
5.3 Magnetic Resonance Guided High-Intensity Focused
Ultrasound Surgery (MRgFUS) (CPT 0398T) for the treatment of essential
tremor is unproven.
5.4 External trigeminal nerve stimulation
(eTNS), also referred to as transcutaneous supraorbital neurostimulation (t-SNS),
for the prevention and/or treatment of migraines is unproven.
- END -